Megatil O
Natural health product licensed in Canada
- Licence holder
- Prébionature Inc.
- NPN or DIN-HM
- 80015982
- Status
- Active licence
- Licence date
- 16 February 2010
- Revision date
- 21 September 2016
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Bifidobacterium longum Source : CNCM I-3470 | 750 Millions d'UFC | Not calculated |
| Lactobacillus rhamnosus Source : CNCM i-1720 | 2.75 Milliards d'UFC | Not calculated |
| Bifidobacterium bifidum Source : CNCM I-3426 | 250 Millions d'UFC | Not calculated |
| Bifidobacterium infantis Source : CNCM I-3424 | 100 Millions d'UFC | Not calculated |
| Lactobacillus casei Source : CNCM I-3429 | 500 Millions d'UFC | Not calculated |
Non-medicinal ingredients
Inuline, Maltodextrine, Acide ascorbique, Stéarate de magnésium, Dioxyde de titane, Hypromellose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes et adolescents | minimum: 12 years | 1 Capsule | 2 Tous les jours |
Uses authorised in Canada
Source de probiotiques. Contribue à soutenir la santé intestinale/ gastrointestinale.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Cesser l'utilisation et consulter un praticien de soins de santé si des symptômes de troubles digestifs (e.g. diarrhée) se manifestent, s'aggravent ou persistent au-delà de 3 jours. Ce produit est entré en contact avec du lait ou du soya. Ne consommez pas ce produit si vous êtes allergique au lait ou au soya.
- Contre-indications
Ne pas utiliser si vous souffrez de nausées, de la fièvre, de vomissements, de diarrhée sanglante ou de douleurs abdominales intenses. Ne pas utiliser si vous souffrez d'un déficit immunitaire (e.g. sida, lymphome, patients subissant un traitement prolongé aux corticostéroids).
Source
Official Health Canada record, licence 80015982
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2016. Photograph the packaging to check whether it has changed. Photograph the packaging